The Effect of Abaloparatide-SC on Fracture Risk Is Independent of Baseline FRAX Fracture Probability: A Post Hoc Analysis of the ACTIVE Study.
about
Investigational anabolic agents for the treatment of osteoporosis: an update on recent developments.Abaloparatide: Review of a Next-Generation Parathyroid Hormone Agonist.MANAGEMENT OF ENDOCRINE DISEASE: Novel anabolic treatments for osteoporosis.Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide.FRAX-based intervention and assessment thresholds in seven Latin American countries.Management of Patients With High Baseline Hip Fracture Risk by FRAX Reduces Hip Fractures-A Post Hoc Analysis of the SCOOP Study.
P2860
The Effect of Abaloparatide-SC on Fracture Risk Is Independent of Baseline FRAX Fracture Probability: A Post Hoc Analysis of the ACTIVE Study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The Effect of Abaloparatide-SC ...... Analysis of the ACTIVE Study.
@en
type
label
The Effect of Abaloparatide-SC ...... Analysis of the ACTIVE Study.
@en
prefLabel
The Effect of Abaloparatide-SC ...... Analysis of the ACTIVE Study.
@en
P2093
P2860
P356
P1476
The Effect of Abaloparatide-SC ...... c Analysis of the ACTIVE Study
@en
P2093
Anders Oden
Eugene V McCloskey
Helena Johansson
John A Kanis
Lorraine Fitzpatrick
Sara Modin
P2860
P304
P356
10.1002/JBMR.3163
P577
2017-06-26T00:00:00Z